Page last updated: 2024-08-16

ribavirin and c-peptide

ribavirin has been researched along with c-peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Devries, JH; Gelderblom, HC; Hamann, D; Hoekstra, JB; Jansen, PL; Reesink, HW; Schreuder, TC; Weegink, CJ1
Barker, P; Dahl-Jørgensen, K; Hanssen, KF; Hessel, TW; Hyöty, H; Johannesen, J; Krogvold, L; Lindblom, N; Ludvigsson, J; Mynarek, IM; Mørk, FB; Ponzi, E; Roald, T; Westman, J1

Trials

1 trial(s) available for ribavirin and c-peptide

ArticleYear
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial.
    Nature medicine, 2023, Volume: 29, Issue:11

    Topics: Adolescent; Antiviral Agents; C-Peptide; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Ribavirin

2023

Other Studies

1 other study(ies) available for ribavirin and c-peptide

ArticleYear
High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:1

    Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; DNA Probes, HLA; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2008